Skip to main content
. 2021 Dec 30;13(1):455–468. doi: 10.1080/21655979.2021.2009410

Figure 4.

Figure 4.

Reversine combined with miR-21-5p inhibitor weakens the tumor growth of HBC in vivo (a) Tumor growth curves in xenograft formation assay, and the representative images of xenograft tumors dissected from the nude mice. (b) The tumor weight of xenograft tumors dissected from the nude mice. ** P < 0.001 compared to antagomiR-NC group. ## P < 0.001 compared to 1.0 mg/kg+antagomiR group.